. Renal epithelial cells constitutively produce a protein that blocks adhesion of crystals to their surface. Am J Physiol Renal Physiol 287: F373-F383, 2004. First published April 20, 2004 10.1152/ajprenal.00418.2003.-Attachment of newly formed crystals to renal tubular epithelial cells appears to be a critical step in the development of kidney stones. The present study was undertaken to identify autocrine factors released from renal epithelial cells into the culture medium that inhibit adhesion of calcium oxalate crystals to the cell surface. A 39-kDa glycoprotein that is constitutively secreted by renal cells was purified by gel filtration chromatography. Amino acid microsequencing revealed that it is novel and not structurally related to known inhibitors of calcium oxalate crystallization. Hence, it was named crystal adhesion inhibitor, or CAI. Immunoreactive CAI was detected in diverse rat tissues, including kidney, heart, pancreas, liver, and testis. Immunohistochemistry revealed that CAI is present in the renal cell cytosol and is also on the plasma membrane. Importantly, CAI is present in normal human urine, from which it can be purified using calcium oxalate monohydrate crystal affinity chromatography. CAI could be an important defense against crystal attachment to tubular cells and the subsequent development of renal stones in vivo.
NEPHROLITHIASIS IS AN EXTREMELY common condition in the United States, affecting up to 10% of the population at some point during their lives (26, 32) . Although many affected individuals have identifiable urinary metabolic risk factors, such as excessively concentrated urine that may contain too much calcium, uric acid, or oxalate, or perhaps too little citrate, many do not (12) . Therefore, the concentration of these urinary constituents does not appear to fully explain the formation of renal stones. In addition, nucleation and growth of individual crystals appear unlikely to produce particles large enough to occlude the nephron lumen in vivo (15) . Recent evidence suggests, that in many calcium oxalate stone formers, the earliest changes may be depositions of calcium phosphate in the medullary interstitium, which then serve as a nidus for a calcium oxalate stone (14) . The processes that mediate calcium phosphate deposition and its evolution into calcium oxalate stones remain to be determined. In more marked hyperoxaluric states (e.g., enteric or primary hyperoxaluria), direct adhesion of calcium oxalate crystals to renal epithelial cells may predominate (14) . Therefore, our laboratory (19 -24) and others (29, 30, 37, 38, 43) have sought to identify regulatory mechanism(s) by which urinary calcium oxalate and calcium phosphate crystals in tubular fluid bind to renal epithelial cells, are retained in the kidney, and become a nidus for stone formation.
Previous studies have demonstrated that anionic molecules in tubular fluid can coat calcium oxalate monohydrate (COM) and hydroxyapatite (HA) crystals, making them less likely to bind to renal cells in culture (20) . Effective anions include the small molecule citrate as well as the glycoprotein osteopontin (20) . During our studies, we unexpectedly observed that renal epithelial cells in culture produce a factor that markedly inhibits adhesion of exogenous COM crystals to their surface. In this report, we identify and characterize this novel factor.
MATERIALS AND METHODS
Cell culture. Nontransformed African green monkey renal epithelial cells of the BSC-1 line (36) were grown in Dulbecco-Vogt modified Eagle's medium containing 25 mM glucose (DMEM) at 38°C in a CO 2 incubator, as previously described (24) . To prepare high-density, quiescent BSC-1 cultures, 1 ϫ 10 6 cells/35-mm plastic plate (9.62 cm 2 , Nunc, Naperville, IL) were plated in DMEM containing 1% calf serum and 1.6 M biotin. Three days later, when they were confluent, the medium was aspirated and replaced with fresh medium containing 1% calf serum and 1.6 M biotin. Cells were plated in 1% calf serum, and 3 days later (day 6) the medium was changed to DMEM containing 0.01% calf serum. BSC-1 cells were routinely used for study on day 9 after being plated. Madin-Darby canine kidney (MDCK) type I cells were a generous gift of Carl Verkoelen (Erasmus University, Rotterdam, The Netherlands). To prepare high-density, quiescent MDCKI cultures, 1 ϫ 10 6 cells/ 35-mm plastic plate (9.62 cm 2 , Nunc) were plated in DMEM containing 10% calf serum and 1.6 M biotin. Two days later, when they were confluent, the medium was aspirated and replaced with fresh medium containing 5% calf serum and 1.6 M biotin. The monolayer was used for study the next day. Rat inner medullary collecting duct (cIMCD) cells were a generous gift of Jack Kleinman (Medical College of Wisconsin, Milwaukee, WI). To prepare confluent cIMCD cultures, 1 ϫ 10 6 cells/35-mm plastic plate (9.62 cm 2 , Nunc) were plated in DMEM containing 1% calf serum and 1.6 M biotin. Two days later, when they were confluent, the medium was aspirated and replaced with fresh medium containing 1% calf serum and 1.6 M biotin. The monolayer was used for study the next day.
Crystal binding assay. To quantitate crystal binding, 200 g/ml of [ 14 C]COM crystals were added to confluent monolayers of cells whose medium had been replaced by medium conditioned (CM) by the cells for different amounts of time, or with fresh DMEM or PBS. Two minutes later, monolayers were washed three times with PBS, and the cell-associated radioactivity was counted, as described previously (19) .
Preparation of antibodies against crystal adhesion inhibitor. After its isolation, crystal adhesion inhibitor (CAI) was subjected to amino acid microsequencing. The amino acid sequence information was employed to prepare synthetic peptides for use as antigens to generate polyclonal antibodies to CAI. The potential antigenicity (hydrophilicity) of the different peptide fragments was compared by using computer software programs based on known algorithms to choose the optimal antigenic sequence for synthesis (MacVector, Acelrys, San Diego, CA). The sequence of the NH 2-terminal 16 amino acids and that of a 13-amino acid internal fragment were each used to prepare a synthetic peptide at the University of Chicago Protein-Peptide Core Facility (NH 2-terminal 16 amino acids: NH2-Lys-Ile-Asn-Gly-GlyGly-Ala-Thr-Leu-Pro-Gln-Pro-Leu-Tyr-Gln-Thr-COOH; 13 amino acid-peptide internal fragment: NH 2-Leu-Asn-Asn-Asp-Tyr-Ser-GlnPhe-Gly-Thr-Gly-Thr-Lys-COOH). Each peptide was linked to a branched polylysine backbone, thereby increasing its multiplicity in a "multiple antigenic peptide system" (MAPS) (27) . These "MAPSpeptides" were used as distinct antigens to immunize rabbits (Pocono Rabbit Farm and Laboratory, Canadenesis, PA). Antibody 1 was prepared against the 16-mer peptide, antibody 2 against the 13-mer. Each antibody reacted strongly against the MAPS-protein antigen that elicited it when evaluated in an ELISA.
The MAPS-peptides were coupled to ECH Sepharose 4B beads (Pharmacia) in carbodiimide at pH 4.5 during an overnight incubation (13) . MAPS-antigen columns were prepared and equilibrated with 10 mM Tris, pH 7.5. A solution of the immune serum diluted 1:10 in 10 mM Tris (pH 7.5) was passed over the column three times. The columns were washed with 10 mM Tris (pH 7.5), then 10 mM Tris (pH 7.5) plus 0.5 M NaCl, and finally eluted with 100 mM glycine (pH 2.5) (10) .
Confocal microscopy. MDCKI cells or cIMCD cells grown to confluence on coverslips were each rinsed twice with PBS and fixed using 3.7% formaldehyde in PBS for 10 min. Fixed cells were permeabilized with 0.1% Triton X-100, or were not permeabilized, and then processed. Cells were then rinsed three times with PBS (5 min each) and incubated with 1% goat serum for 1 h to block nonspecific binding sites. The goat serum was aspirated, and the cells were incubated overnight with polyclonal anti-CAI antibody and monoclonal anti-actin (BD Transduction Labs, Franklin Lakes, NJ) or anti-nucleolin antibodies (MBL International, Woburn, MA) at 4°C in a humidified chamber. Next, cells were washed with PBS (5 min ϫ 3) and then incubated for 1 h with an anti-mouse IgG conjugated with Alexa-488 and anti-rabbit IgG conjugated with Texas red (BD Transduction Labs). The cells were then washed with PBS (10 min ϫ 3), and the coverslips were mounted onto glass slides using Slow-Fade Fig. 1 . Inhibition of calcium oxalate monohydrate (COM) crystal binding to renal epithelial BSC-1 cells by conditioned medium (CM). High-density, quiescent cultures were prepared, and the medium was aspirated and replaced with either fresh medium or 3-day CM from other quiescent cultures. Crystal binding was markedly reduced (95%) by medium from quiescent cultures compared with fresh medium. Each value is the mean Ϯ SE of 3 cultures. CPM, counts/min. *P Ͻ 0.01 vs. fresh DMEM. High-density, quiescent cultures were prepared. The medium was then aspirated and replaced with PBS to which a specified quantity of CM was added (0 to 5 ml). [ 14 C]COM crystal binding was progressively diminished by increasing amounts of CM, with maximal inhibition occurring after addition of Ͼ2.5 ml. Each value is the mean Ϯ SE of 6 cultures. *P Ͻ 0.01 vs. control (0 ml of CM). (Molecular Probes, Eugene, OR). The XY and XZ sections were scanned using a LSM 510 confocal microscope (Carl Zeiss, Oberkochen, Germany) equipped with an Axiovert 100M microscope and a c-Apochromat 63/1.2 numerical aperture water-immersion lens. Alexa 488 and Texas red were excited with the 488-and 568-nm line, respectively, from an argon-krypton laser. Emissions for Alexa 488 and Texas red were collected at 505-550 nm and Ͼ585 nm, respectively.
Preparation of cellular extracts. Cell protein extracts were prepared by rinsing a monolayer of BSC-1 or MDCKI cells with PBS containing PMSF (1 mM) and aprotinin (0.15 U/ml) and then lysing the cells in 2% SDS containing 5% ␤-mercaptoethanol and 1 mM PMSF. Tissue blocks (ϳ1 mm 3 ) were also obtained from specified organs of normal male Sprague-Dawley rats (ϳ250 g) at the time of death, placed in 1 ml of the cell lysis buffer, and sheared with an 18-gauge needle (20 times) after being placed in buffer.
Preparation of cellular fractions. Monolayers of BSC-1 cells were rinsed with ice-cold PBS and scraped into a centrifuge tube containing 10 ml of homogenization buffer (0.3 M sucrose, 0.05 M Tris, pH 7.4) with Complete protease inhibitor cocktail (Boehringer Mannheim). Cells were homogenized by passage through an 18-gauge needle (20 times) and centrifuged twice in succession (600 g ϫ 10 min) to obtain a nuclear fraction. The supernatants were combined and centrifuged (10,000 g ϫ 30 min) to remove the mitochondrial and lysosomal fractions. The supernatants were then centrifuged (100,000 g ϫ 120 min) to prepare microsomal (pellet) and cytosolic fractions (supernatant). Medium from 3-day quiescent BSC-1 cultures containing 0.01% calf serum (250 ml) was collected and CAI activity was isolated as described in RESULTS. A: eluate was applied to a Biogel A 0.5 M column. Fractions were assayed for CAI activity, which eluted at an apparent molecular mass of ϳ80,000 Da. B: Na-EDTA was added to the DEAE eluate to achieve a final concentration of 50 mM, and 2 days later this eluate was applied to the same Biogel A 0.5 M column. CAI activity now eluted with an apparent molecular mass of ϳ15,000 Da.
SDS-PAGE and immunoblotting.
Concentrated fractions containing CAI activity were electrophoresed on a 1.5-mm-thick, 10% polyacrylamide gel at 100-V constant current using a Mini-Protean II apparatus (Bio-Rad, Hercules, CA). After electrophoresis, the gel was either stained using 0.1% Coomassie blue or transferred onto a Sequi-Blot membrane (Bio-Rad) in CAPS buffer (10 mM CAPS, 40% methanol, pH 11.0) at a 250-mA constant current for 60 min using a Trans-Blot apparatus (Bio-Rad). Blots were stained using Coomassie blue or probed with the monospecific antibodies raised against CAI MAPSpeptides, and the protein of interest was detected using a horseradish peroxidase-conjugated secondary antibody and enhanced chemiluminescence kit (Amersham Pharmacia Biotech, Piscataway, NJ).
Microsequencing of COM-binding protein.
In the University of Chicago Amino Acid and Protein Core, Rockefeller Institute Protein Core, and Mayo Clinic Protein Core, CAI was subjected to in situ enzymatic digestion with Asp N protease, Lys C protease, or trypsin. The resulting peptide fragments were separated by reverse-phase HPLC, collected directly onto a polyvinylidine difluoride strip, treated with biobrene in methanol, and then subjected to microsequencing (Applied Biosystems Procise 492 HT, Applied Biosystems, Foster City, CA). The data were analyzed with ABI model 610A dataanalysis software (Applied Biosystems).
RESULTS

Cultured renal cells constitutively release CAI. Binding of COM crystals to cells was markedly reduced in the presence of CM. [
14 C]COM crystal adhesion (2-min assay) was reduced by 95% when radioactive crystals were added to cultures containing medium that had been exposed to the cells for 3 days compared with monolayers in which the medium was replaced with fresh DMEM containing 0.01% calf serum or PBS (Fig.  1 ). To investigate this observation further, 3-day quiescent CM was replaced with PBS to which increasing quantities of CM were added. A concentration-dependent decline in crystal adhesion was observed as the amount of CM was increased (Fig.  2) . Inhibition was maximal when Ͼ2.5 ml of CM were added. These initial observations suggested that the cells release a factor (CAI) into CM that blocks adhesion of COM crystals to cells.
To define the kinetics on the appearance of CAI activity, BSC-1 cells were grown to high density and made quiescent in fresh medium containing 0.01% calf serum. The cells were allowed to condition the medium for different amounts of time. Then, the CM was assayed for its capacity to inhibit adhesion of [ 14 C]COM crystals to BSC-1 cells during the next 4 days. Significant CAI activity was detected on day 2 and was greater on day 3 (Fig. 3) . Minimal additional release of CAI from the cells into the medium was apparent after 3 days.
Characterization of CAI. CAI activity in CM was retained by ultrafiltration with a YM 30 membrane (Amicon) that allows passage of molecules with an M r of Ͻ30,000 and is resistant to freezing, heating to 56°C for 30 min, or boiling for 10 min (41). Treatment with heparinase I (5 U/ml, 37°C, pH 7.4, 4 h) (25) , heparinase III (0.5 U/ml, 43°C, pH 7.4, 4 h) (25) , and chondroitinase ABC (0.5 U/ml, 37°C, pH 7.4, 4 h) (44) failed to abolish activity, as did treatment with DNAse (10 ng/ml, 23°C, pH 7.4, 1 h) or nitrous acid (0.25 M, 23°C, pH 7.4, 2 h) (11). Activity was abolished by treatment with neuraminidase (1 U/ml, pH 5.5, 37°C, 1 h) (40) or sodium hydroxide (0.2 M, 23°C, 18 h) (11) . Utilization of the DIG glycan detection kit (Boehringer Mannheim), as directed by the manufacturer, suggested that the factor contained carbohydrate, as was inferred by a positive carbazole reaction (6) . When applied to a DEAE-Sepharose anion-exchange column, CAI eluted with 0.4 M NaCl. Treatment with proteinase K did not abolish activity but did change the elution profile from the Biogel A 0.5M sizing column (see below). Together, these observations suggest that CAI is anionic, contains carbohydrate and possibly sialic acid residues, and has an M r Ͼ30,000.
Purification of CAI from CM. Utilizing the above information, a strategy was developed to purify CAI from CM. Medium from 3-day quiescent BSC-1 cultures containing 0.01% calf serum was collected and then passed through a 0.22-m filter to remove any cells or debris. CM was then ultrafiltered through a YM 30 membrane (Amicon) to eliminate molecules with an apparent M r of Ͻ30,000. The fraction containing molecules with M r Ͼ 30,000 was loaded onto a DEAESepharose anion-exchange column and was eluted with 0.4 M NaCl. The eluate was then applied to a Biogel A 0.5 M sizing column. Activity was detected in fractions consistent with an Fig. 5 . Isolation of CAI by COM crystal affinity chromatography. Fractions containing CAI activity eluted from a Biogel sizing column were pooled, combined, concentrated, and incubated with COM crystals overnight. Then, crystals were rinsed and dissolved with 250 mM Na-EDTA to release molecules bound to the crystals. Material eluted from the crystals inhibited adhesion of COM crystals to BSC-1 cells. A: CAI isolated by dissolution of COM crystals produced a single sharp band with an apparent Mr of 39,000 Da when resolved by SDS-PAGE (20% polyacrylamide) under reducing conditions and stained with silver. B: this material also eluted in a single sharp peak from a C4 reverse-phase HPLC column at 51% acetonitrile (ACN). OD, optical density.
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CRYSTAL ADHESION INHIBITOR PROTEIN apparent M r between 60,000 and 100,000, with peak activity at an apparent M r of 80,000 (Fig. 4A) . However, when the DEAE eluate was incubated with EDTA for 2 days at 4°C, CAI eluted from the Biogel column in a sharp peak with an apparent M r of ϳ15,000 (Fig. 4B) . Therefore, it appears that CAI released from cells forms an aggregate when CM is concentrated, and the aggregate can be dissociated by chelation of its associated cations (e.g., calcium and magnesium) with EDTA. For its subsequent purification, CAI was chelated with EDTA before separation on the sizing column because the activity eluted in a sharper peak in the dissociated form (Fig. 4B) .
To purify CAI further, we took advantage of our previous observations which indicated that molecules inhibiting COM crystal adhesion to cells act by coating the crystals (20) . Therefore, an EDTA-treated DEAE eluate was loaded onto a Biogel column, and the fractions demonstrating greatest activity ( Fig. 4B) were concentrated with a Centricon microconcentrator (10-kDa cutoff, Millipore, Bedford, MA) and incubated with COM crystals (100 mg) in PBS overnight at 4°C in a 2-ml tube subjected to end-over-end rotation. The next day, crystals were washed, in succession, with supersaturated calcium oxalate solution (2 ml) containing no NaCl, then 1 M NaCl, and finally 4 M NaCl (twice), each for 1 h. Antiadhesion activity was absent in the PBS and all wash fractions, suggesting that CAI was tightly associated with the crystals. COM crystals were then dissolved by incubation in 10 mM Tris (pH 8) containing 250 mM Na-EDTA. This solution was replaced daily and saved until the crystals were completely dissolved. 
CAI, crystal adhesion inhibitor; UP, uropontin; UPTF1, human urinary prothrombin fragment 1. References are in parentheses. *Values are mols/100 ml. †Total net charge on the protein core of each molecule was calculated by assuming that all aspartic acid plus asparagine and glutamic acid plus glutamine residues are anions, and that all histidine, lysine, and arginine residues are cations. 
A, Ala, alanine; H, His, histidine; P, Pro, proline; W, Trp, tryptophan; C, Cys, cysteine; I, Ile, isoleucine; Q, Gln, glutamine; Y, Tyr, tyrosine; D, Asp, aspartic acid; K, Lys, lysine; R, Arg, arginine; E, Glu, glutamic acid; L, Leu, leucine; S: Ser, serine; F: Phe, phenylalanine; M, Met, methionine; T, Thr, threonine; G, Gly, glycine; N, Asn, asparagine; V, Val, valine; X, no definite assignment, possibly a glycosylated amino acid; ( ), uncertainty about assignment of amino acid at this position; Asp N, Asp-N protease cleavage; Lys C, Lys-C protease cleavage; Tr, Trypsin cleavage; CM, BSC-1 cell-conditioned medium; Ur, human urine. The amino acid sequence of the NH2 terminus and 12 internal fragments of CAI are shown. To obtain internal sequences, purified protein was digested using Lys-C or Asp-N protease, and the fragments were separated by reverse-phase HPLC for gas-phase microsequencing. The amino acid sequence in fragment 3 used to produce the multiple antigenic peptide system (MAPS)-peptides for the preparation of monospecific antibodies is shown in italics and is underlined. 
After dissolution of the crystals, the pooled material was placed in Spectrapor dialysis tubing (12-to 14-kDa cutoff) and dialyzed at 4°C against 10 mM sodium phosphate buffer to remove EDTA, calcium, and oxalate. The volume of the dialyzed material was reduced with a Centricon microconcentrator (10-kDa cutoff). Material recovered after dissolution of the crystals demonstrated CAI activity in the crystal binding assay, produced a single band on an SDS-PAGE (20%) with an apparent M r of 39 kDa (Fig. 5A) , and was eluted from a reverse-phase HPLC C 4 column as a single sharp peak at 51% acetonitrile (utilizing a 1:80% acetonitrile gradient containing 0.1% trifluoroacetic acid) (Fig. 5B) . Material produced by dissolution of control crystals (not coated with CAI) did not exhibit CAI activity. Therefore, CAI appears to be a hydrophobic glycoprotein having marked affinity for COM crystals and an apparent M r of 39 kDa. As yet unidentified physical/chemical properties of CAI apparently cause it to migrate differently through a sizing column composed of agarose beads (apparent M r ϳ15 kDa) than in 20% polyacrylamide (apparent M r ϳ39 kDa).
Amino acid composition and sequence of CAI. Pooled fractions containing CAI activity from the Biogel sizing column were combined, concentrated, and rinsed with 10 mM Tris (pH 7.4) using a Centricon-10 microconcentrator, and subjected to SDS-PAGE (20%) followed by electrophoretic transfer to a polyvinylidine difluoride membrane (Imobilon-PSQ, Millipore) in a transverse electric field of 20 V overnight in 10 mM CAPS buffer containing 10% methanol, pH 11. Blots were stained with Coomassie blue (0.1%), destained with 50% methanol and 10% acetic acid, and the predominant band at 39 kDa was excised. Amino acid compositional analysis, performed at the University of Chicago Amino Acid and Protein Core Lab, is shown in Table 1 , in which CAI is compared with three other urinary crystallization inhibitors, uropontin (UP) (31) , human urinary prothrombin fragment 1 (UPTF1) (33) , and bikunin (34) . Whereas the estimated total net charges on the protein core of UP (Ϫ25.5), UPTF1 (Ϫ14.3), and bikunin (Ϫ7.4) are each negative, CAI (Ϫ2.1) was nearly neutral. Therefore, unlike these three known anionic glycoproteins (UP, UPTF1, bikunin), carbohydrate (possibly sialic acid residues) rather than acidic amino acids appears to contribute importantly to the strongly anionic character of CAI glycoprotein. The role of sialic acid is inferred from the observation Fig. 6 . CAI in cellular fractions. BSC-1 cells were fractionated using differential centrifugation, and proteins in the cell fractions were separated by SDS-PAGE, electroblotted, and probed with monospecific antibodies against CAI multiple antigenic peptide system (MAPS)-peptides 1 and 2. Antibody 1 detected CAI in the microsomal fraction, whereas antibody 2 recognized it in both cytosolic and microsomal fractions. Both antibodies also recognized CAI in the nuclear fraction, although this may be artifactual because CAI was not detected in the nuclei by immunofluorescence (see Fig. 7 ). AB, antibody; Nu, nuclear; Mi, mitochondria; Mic, microsome; Cy, cytosol. 
LG-TNLIFSQ CYA---QTSQ VRAFFTRHYG ASALNTNDNA IKANRFVPLP Pseudo ABC
LGFTNLIFSQ CYANATQTQQ VRDFFTRHYG ATANN--DTA ITNHRFVPLP Consensus
LG-TNLIPSQ CYA---QTXQ VR-FFTRH-X A-A-N-----XX-XXFVPLP (3); cotinine BP (cotinine binding protein), protein with cotinine affinity isolated from the membrane of rat brain cells (28); Hirudin-sensitive fibroblast proteinase (HSFP), protein with strong hirudin affinity and proteinase activity isolated from cultured fibroblasts (9); Synov. Stim. Prot (synovial stimulatory protein; GenBank accession no. 1711419), protein isolated from human synovial fluid that activates T cells (7); Pseudomonas (Pseudo) ABC, predicted amino acid sequence of a Pseudomonas gene recently sequenced and reported to GenBank (accession no. 32040700), with homology to a family of bacterial phosphate transporters (17) .
that treatment of partially purified CAI with neuraminidase abolished its CAI activity.
Electroblots of CAI were then submitted for amino acid microsequencing. Results for the NH 2 terminus are shown in Table 2 . To achieve more complete characterization of CAI, additional electroblots of CAI were prepared. The band of interest (M r 39,000) was excised, the eluted protein was subjected to proteolytic cleavage, and the resulting fragments were separated by reverse-phase HPLC and then subjected to microsequencing at the Rockefeller Institute. LysC protease cleavage of electroblotted CAI resulted in the six fragments shown in Table 2 . Microsequencing of additional fragments of CAI produced by cleavage with AspN protease, or by trypsin cleavage of CAI obtained from human urine processed identically to CM (see below), were performed in the Mayo Clinic Protein Core. Where overlap occurred, the sequences from human urine and monkey renal cells were identical (Table 2) . In summary, the sequences for 283 amino acids of CAI fragments are now known. Because the complete amino acid sequences of UP, UPTF1, and bikunin are all known, it is clear that CAI differs from these three glycoprotein inhibitors of COM crystal growth. A search of peptide and nucleic acid sequence databases (2) revealed that CAI is novel but exhibits a homology of its NH 2 terminus to the DING family of proteins (4) ( Table 3) .
Monospecific antibodies against fragments of CAI. The amino acid sequence information in Table 2 was employed to prepare two synthetic MAPS-peptides for use as antigens to generate polyclonal antibodies to CAI in rabbits. Each antibody reacted strongly against the MAPS-peptide antigen that elicited it when evaluated in an ELISA. Each cognate MAPSpeptide was used as an antigen to prepare an affinity-purified Fig. 7 . Visualization of CAI within MadinDarby canine kidney (MDCKI) cells using confocal microscopy. Permeabilized confluent MDCKI cell monolayers on glass coverslips were probed for CAI, actin, and nucleolin (NUC). Cross-sectional XZ scans (perpendicular to cell layer) were obtained using a LSM 510 confocal microscope (magnification ϫ630). Primary antibodies were detected using secondary antibodies conjugated to Texas red (CAI) and Alexa 488 (actin and nucleolin). A and D: CAI visualized as red fluorescence. B and E: actin and nucleolin visualized as green fluorescence. C and F: overlay of green and red fluorescence visualized as yellow fluorescence, depicting colocalization of CAI and actin (C) or nucleolin (F). CAI appears to be mainly cytosolic, although small amounts may also be found in the nucleus. BLM, basolateral membrane; AM, apical membrane. Note that the cells are inverted. Fig. 8 . CAI in diverse rat tissues. Extracts of BSC-1 cells or rat tissues were prepared as described in MATERIALS AND METHODS, separated by SDS-PAGE, electroblotted, and probed with CAI antibody 1. CAI immunoreactivity was present in all tissues with a size distribution that appeared unique for each organ, suggesting that specific isoform profiles may characterize different tissues, or that homologous proteins are present (see Table 3 ). Panc, pancreas.
antiserum from its respective serum as described in MATERIALS AND METHODS. Each of these monospecific antibodies recognized a single protein band whose apparent size was M r 39 kDa when proteins in partially purified CM from BSC-1 cells were separated by SDS-PAGE, and the gels were blotted and probed.
Detection of CAI in renal epithelial cells. Cell protein extracts were prepared by rinsing a monolayer of BSC-1 cells with PBS containing PMSF (1 mM) and aprotinin (0.15 U/ml) and then lysing the cells in 2% SDS containing 5% ␤-mercaptoethanol and 1 mM PMSF. Total cell proteins were separated by SDS-PAGE, electroblotted, and probed with each of the monospecific antibodies against peptide fragments of CAI. Each antiserum recognized a band of M r 39 kDa in the total BSC-1 cell extract, which appears to represent a cell-associated form of the protein (Fig. 6) . CAI was also detected in a cell extract of a second renal epithelial cell line, MDCKI (not shown). As MDCKI cells are derived from the distal tubule, this observation suggests that the factor is produced in a nephron segment in which stone formation seems likely to begin. BSC-1 cells were then fractionated to determine the organelle in which CAI originates or is stored. Antibody 1 detected CAI mainly in microsomes, whereas antibody 2 detected it in the cytosol (Fig. 6 ). Both antibodies also detected small amounts of CAI in the nuclear fraction. MDCKI cells were also examined immunohistochemically using antibody 2. In nonpermeabilized cells, small amounts of CAI were detected on the plasma membrane, perhaps representing ongoing secretion (not shown). In permeabilized cells, CAI appeared to be diffusely distributed in the cytosol, where it partially colocalized with actin (Fig. 7, A-C) . Minimal nuclear staining was observed, whereby CAI partially colocalized with nucleolin (Fig. 7, D-F) . Taken together, these observations suggest that CAI is a cytosolic protein that is secreted by the cells.
To determine the systemic distribution of CAI, the proteins in cellular extracts of diverse rat organs were probed with CAI antibody 1. A 39-kDa band was recognized in all tissues examined, including brain, testis, ureter, spleen, kidney, heart, and pancreas (Fig. 8) . In addition, smaller bands (ϳ 34 kDa) as well as larger bands (ϳ55 and 80 kDa) were recognized in certain tissues, including BSC-1 cell lysates, suggesting that CAI might exist in various isoforms. Note that no 15-kDa bands were detected.
CAI detected in human urine. The results summarized above suggest that CAI is a cytosolic glycoprotein that is secreted by renal epithelial cells into the extracellular fluid, e.g., CM of cultured cells. To determine whether it is released into human urine by the intact kidney, we used the same protocol that was employed to purify CAI from the CM of BSC-1 cells. Fig. 9 . Detection of CAI in normal human urine. One liter of urine was concentrated, eluted from a DEAE-Sepharose anion exchange column with 0.4 M NaCl, treated with EDTA, and active fractions were eluted from a Biogel A 0.5 M sizing column. CAI activity was eluted with an apparent molecular mass of ϳ15,000 Da (not shown), similar to CAI obtained from BSC-1 cell CM as in Fig. 4B . Pooled fractions containing CAI activity were concentrated. The proteins were separated by SDS-PAGE, electroblotted, and probed with each of the 2 monospecific antibodies generated against CAI peptides. A single band with an apparent Mr of 39 kDa was detected by Coomassie blue staining (A) that was detected by each antiserum to CAI (B and C). One liter of human urine from a non-stone-forming adult volunteer was collected using thymol as a preservative to prevent bacterial growth in a protocol approved by the Mayo Clinic IRB. The urine was concentrated with a YM-30 membrane, applied to a DEAE-Sepharose anion-exchange column, and then eluted with 0.4 M NaCl. Sodium-EDTA (50 mM) was added to the eluate, and 2 days later it was applied to a Biogel A 0.5 M column. Fractions 40 -45, which contained CAI activity were combined, and the proteins were separated by SDS-PAGE and electroblotted. When the blot was stained with Coomassie blue, a single prominent band was detected at 39 kDa (Fig. 9A) . Each of the two monospecific antibodies generated against MAPS-peptides of CAI recognized this band (Fig. 9, B and C) .
Because CAI has a strong affinity for COM crystals, they were employed to purify the factor from urine. A 10-fold concentrate of urinary proteins was prepared using an Amicon stir cell and YM-10 membrane. This concentrate (2 ml) was incubated with COM crystals (10 mg) overnight. The crystals were washed twice with PBS and dissolved in 0.5 M EDTA, pH 8. The crystal extract was concentrated and washed using a Centricon microconcentrator (10-kDa cutoff), and its proteins were resolved by SDS-PAGE and electroblotted. A 39-kDa band was recognized by CAI antibody 1 in the crystal extract. The band was then excised from the blot and subjected to NH 2 -terminal microsequencing in the Mayo Clinic Proteomics Core, which confirmed that it was CAI (see Table 3 ). Therefore, CAI in human urine, like that in BSC-1 cell CM, has a strong affinity for COM crystals.
DISCUSSION
The experiments described above demonstrate that monkey renal epithelial cells release a glycoprotein that blocks adhesion of COM crystals to the apical cell surface. This molecule has been named CAI, and it is also found in normal human urine. Renal epithelial cells in culture constitutively produce CAI, suggesting that cells lining the nephron may do so similarly in vivo. Molecular characterization suggests that CAI is a strongly anionic glycoprotein with an apparent M r of 39 kDa. Microsequencing of the NH 2 terminus and 10 fragments has identified a total of 283 amino acids, indicating that CAI is novel.
The NH 2 terminus of CAI bears strong homology to four human proteins in the database (Table 3 ). These are members of the DING family of proteins, named for the characteristic DINGGG amino acid sequence at the NH 2 terminus (4). Members of this family have been isolated from diverse tissues and were identified by their unique biological functions: affinity for the intracellular signaling molecule genestein (breast cancer cells) (3); cell surface cotinine receptor (brain cells) (28) ; affinity for hirudin with proteinase and growth factor activity isolated form fibroblast culture medium (1, 9); and as a T cell stimulator in synovial fluid (GenBank accession no. 1711419) (7) . To date, no gene encoding any of these proteins has been reported (3). The NH 2 terminus of CAI has limited homology to a peptide fragment obtained by dissolving a human kidney stone and separating the resulting matrix proteins by two-dimensional gel electrophoresis (GenBank accession no.1082909) (5). This "urinary stone matrix protein" (Table 4 ) may be a common constituent of human kidney stones because similar peptides were visualized by these investigators on gels prepared from the matrix of three additional urinary stones (5) .
The NH 2 termini of CAI and the DING family of proteins also exhibit significant homology to the predicted amino acid sequence of an ABC phosphate transport protein (17) in the recently sequenced Pseudomonas aeruginosa genome (GenBank accession no. 32040700; Table 3 ). Each of the 11 internal fragments of CAI also bear homology to this predicted protein, some more strongly than others (Table 3) . A weaker homology of the CAI NH 2 terminus to the predicted amino acid sequence of a membrane-bound form of alkaline phosphatase from P. aeruginosa (GenBank accession no. 15595885) (35) and a membrane-bound form of [Fe]-hydrogenase from Desulfovibrio desulficans (GenBank accession no. 1218062) (16) is also apparent in Table 4 . Eight of the 10 internal fragments of CAI also bear weak homology to the predicted amino acid sequence of Pseudomonal alkaline phosphatase, one of a family of bacterial membrane-associated phosphate-binding proteins (18, 35) . Together, the homologies in Tables 3 and 4 hint that CAI is a membrane-associated or cytosolic protein constitutively released by renal epithelial cells and that it, or a homologous DING protein, may also be released by other types of cells, such as breast epithelial cells, brain cells, fibroblasts, or synoviocytes. Although each fragment of CAI has some homology to the predicted sequence of the Pseudomonal ABCtype transporter, certain of the homologies are weaker (e.g., fragments 1, 4, 8, 10 , and 11). We do not believe that CAI is a Pseudomonal contaminant for several reasons: CAI immunoreactivity was detected in both sterile culture medium and sterile human urine, and CAI was found in sterile lysates of cultured renal cells, in which bacterial contamination is highly unlikely. Importantly, nonrenal proteins homologous to CAI have been isolated by independent investigators from diverse tissues using different purification techniques. We believe that as a member of the DING family of proteins, CAI bears significant nucleotide and amino acid sequence homology to the Pseudomonas ABC phosphate transporter protein that couples ATP hydrolysis to ionic transport (8) . The functional significance of these homologies remains to be determined.
As CAI is a constituent of human urine, it is likely that the glycoprotein is present in sufficient quantities in tubular fluid in vivo to coat crystals and prevent their adhesion to renal epithelial cells. In susceptible individuals, CAI could become incorporated into the matrix of kidney stones (5), a hypothesis that can now be tested using our antisera. Further study of CAI, and the factors that regulate its production, could increase our understanding of the mechanisms that underlie kidney stone formation. Because crystals adhere avidly to proliferating renal cells in culture (39) , it is possible that CAI production in vivo could increase to protect cells against crystal binding during repair after tubular injury. In addition, in certain individuals, production of CAI glycoprotein that is either quantitatively or functionally defective could predispose them to kidney stone formation. Should CAI-deficient patients be detected, adhesion of crystals to tubular cells would be expected to occur more readily, and once retained in the nephron, these crystals could grow into kidney stones. Studies are ongoing to test this hypothesis and clone the gene that encodes CAI. 
